Citations:SARS-CoV-2

Translingual citations of SARS-CoV-2

(a virus discovered in 2019):

• 2020 April, Lu, Xiaoxia, Liqiong Zhang, Hui Du, Jingjing Zhang, Yuan Y. Li, Jingyu Qu, Wenxin Zhang et al., “SARS-CoV-2 infection in children”, in New England Journal of Medicine, volume 382, number 17, →DOI:

  As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited.

• 2020 August, Gehanno, J. F., V. Bonneterre, P. Andujar, J. C. Pairon, C. Paris, A. Petit, C. Verdun-Esquer, Q. Durand-Moreau, et P. Brochard, “Arguments pour une possible transmission par voie aérienne du SARS-CoV-2 dans la crise COVID-19”, in Archives des Maladies Professionnelles et de l'Environnement, volume 81, →DOI, page 306:

  La connaissance des modes de transmission du SARS-CoV-2 est un élément fondamental dans l’élaboration des stratégies de prévention en santé au travail et en santé publique dans le cadre de la gestion de crise du Covid-19.

  Understanding the modes of transmission of SARS-CoV-2 is a fundamental element in developing prevention strategies for occupational and public health to manage the COVID-19 crisis.

• 2021 March, Davies, Nicholas G., Christopher I. Jarvis, W. John Edmunds, Nicholas P. Jewell, Karla Diaz-Ordaz, and Ruth H. Keogh, “Increased mortality in community-tested cases of SARS-CoV-2 lineage B. 1.1.7”, in Nature, →DOI, page 1:

  SARS-CoV-2 lineage B.1.1.7, a variant that was first detected in the UK in September 2020, has spread to multiple countries worldwide.

• 2021 June, Krause, Philip R., Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, et al., “SARS-CoV-2 Variants and Vaccines”, in New England Journal of Medicine, →DOI:

  In addition to continuing to track the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are four major priorities for the global response to variants of concern.

(the disease caused by the virus):

• 2020 October 22, Dixon, Brian E., Kara Wools-Kaloustian, William F. Fadel, Thomas J. Duszynski, Constantin Yiannoutsos, Paul K. Halverson, and Nir Menachemi, “Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations”, in medRxiv‎^[1], →DOI, →PMID:

  Our findings provide robust evidence to the growing body of studies that identify anosmia and ageusia as important symptoms of SARS-CoV-2 infection.